Activation of human T lymphocytes by Leishmania lipophosphoglycan - PubMed (original) (raw)

Activation of human T lymphocytes by Leishmania lipophosphoglycan

M Kemp et al. Scand J Immunol. 1991 Feb.

Abstract

This study describes Leishmania antigen-induced activation of lymphocytes isolated from Kenyan donors, previously treated for visceral leishmaniasis, and from Danish and Kenyan controls. Peripheral blood mononuclear cells (PBMC) from cured Kala-Azar patients proliferated and produced Interferon-gamma in vitro in response to lipophosphoglycan (LPG) isolated from Leishmania major. The proliferative response was mainly due to activation of CD2-positive T cells. PBMC from controls did not respond to LPG, but to sonicates prepared from both L. major and L. donovani promastigotes. The surface glycoprotein GP 63 failed to activate PBMC from any of the donors tested. These results show that the individuals cured from visceral leishmaniasis had expanded T-cell clones recognizing LPG, conceivably as a result of Leishmania infection. The LPG preparation was without detectable protein contamination. Thus, the results suggest that human T lymphocytes can respond to glycolipid antigens.

PubMed Disclaimer

Similar articles

• Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients.
  Kurtzhals JA, Hey AS, Jardim A, Kemp M, Schaefer KU, Odera EO, Christensen CB, Githure JI, Olafson RW, Theander TG, et al. Kurtzhals JA, et al. Clin Exp Immunol. 1994 Jun;96(3):416-21. doi: 10.1111/j.1365-2249.1994.tb06044.x. Clin Exp Immunol. 1994. PMID: 8004810 Free PMC article.
• Cellular and humoral immune responses in a population from the Baringo District, Kenya to Leishmania promastigote lipophosphoglycan.
  Kurtzhals JA, Hey AS, Theander TG, Odera E, Christensen CB, Githure JI, Koech DK, Schaefer KU, Handman E, Kharazmi A. Kurtzhals JA, et al. Am J Trop Med Hyg. 1992 Apr;46(4):480-8. doi: 10.4269/ajtmh.1992.46.480. Am J Trop Med Hyg. 1992. PMID: 1575296
• Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi.
  Vinhas V, Freire M, Bacellar O, Cunha S, Rocha H, Carvalho EM. Vinhas V, et al. Braz J Med Biol Res. 1994 May;27(5):1199-205. Braz J Med Biol Res. 1994. PMID: 8000341
• Role of T cells in immunity to the intracellular pathogen, Leishmania major.
  Titus RG, Theodos CM, Kimsey PB, Shankar A, Hall L, McGurn M, Povinelli L. Titus RG, et al. Subcell Biochem. 1992;18:99-129. doi: 10.1007/978-1-4899-1651-8_4. Subcell Biochem. 1992. PMID: 1485362 Review. No abstract available.

Cited by

• Advances in Leishmania Vaccines: Current Development and Future Prospects.
  Ayala A, Llanes A, Lleonart R, Restrepo CM. Ayala A, et al. Pathogens. 2024 Sep 20;13(9):812. doi: 10.3390/pathogens13090812. Pathogens. 2024. PMID: 39339003 Free PMC article. Review.
• A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan.
  Amprey JL, Im JS, Turco SJ, Murray HW, Illarionov PA, Besra GS, Porcelli SA, Späth GF. Amprey JL, et al. J Exp Med. 2004 Oct 4;200(7):895-904. doi: 10.1084/jem.20040704. J Exp Med. 2004. PMID: 15466622 Free PMC article.
• The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC).
  Gasim S, Elhassan AM, Kharazmi A, Khalil EA, Ismail A, Theander TG. Gasim S, et al. Clin Exp Immunol. 2000 Mar;119(3):523-9. doi: 10.1046/j.1365-2249.2000.01163.x. Clin Exp Immunol. 2000. PMID: 10691926 Free PMC article.
• Visceral leishmaniasis (kala-azar) after a visit to the Mediterranean region.
  Rudi J, Racz P, Hörner M, Kommerell B. Rudi J, et al. Clin Investig. 1993 Aug;71(8):616-9. doi: 10.1007/BF00184486. Clin Investig. 1993. PMID: 8219656
• Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients.
  Kurtzhals JA, Hey AS, Jardim A, Kemp M, Schaefer KU, Odera EO, Christensen CB, Githure JI, Olafson RW, Theander TG, et al. Kurtzhals JA, et al. Clin Exp Immunol. 1994 Jun;96(3):416-21. doi: 10.1111/j.1365-2249.1994.tb06044.x. Clin Exp Immunol. 1994. PMID: 8004810 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley